| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |